A Study of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopathic Inflammatory Myopathies (r/r IIM)

Clinical trial NCT07331272 · RECRUITING

Trial details

NCT number: NCT07331272
Sponsor: Nanjing Legend Biotech Co.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus (SLE)Idiopathic Inflammatory Myopathies(IIM)

Start date: 2026-01-29
Primary completion: 2028-01-31
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.